Solid Cancer

Study data from C. Christodoulou and co-authors update knowledge of solid cancer

Published in Cancer Weekly, April 28th, 2009

"Erythropoietin corrects and prevents anemia and decreases the need for red blood cell (RBC) transfusions; its impact on quality, of life (QOL) of cancer patients receiving chemotherapy, is not clear. 399 patients with solid tumors and Hb level of <= 12 g/dl receiving chemotherapy, were randomized to receive or not 10,000 IU epoetin-a thrice weekly," researchers in Athens, Greece report.

"QOL was measured by, the Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale and various subscales at baseline. at two months and at the end of the study. Changes in the average QOL scores were similar in the two groups. The improvement in Hb levels was significantly...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2009-04-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry